Literature DB >> 18556120

Frontal lobe structure and executive function in migraine patients.

Nicole Schmitz1, Enrico B Arkink, Marieke Mulder, Katya Rubia, Faiza Admiraal-Behloul, Guus G Schoonman, Mark C Kruit, Michel D Ferrari, Mark A van Buchem.   

Abstract

Neuroimaging studies have identified frontal lobe brain abnormalities in migraineurs. Neuropsychological investigations highlighted frontal lobe related cognitive impairments in migraineurs, including working memory and executive function deficits. The relationship between brain anatomy and cognitive function in migraine, however, is unclear. The aim of this study was to simultaneously investigated cortex structure and executive function (EF) in patients with migraine and control subjects. Thus, we assessed grey matter (GM) density in 25 adult patients with migraine, compared to age and sex-matched control subjects, using magnetic resonance imaging (MRI) and voxel-based-morphometry (VBM), and we measured EF in the same population, employing three EF tasks of the Maudsley attention and response suppression (MARS) battery. Migraineurs, compared to control subjects, showed decreased frontal and parietal lobe GM density and slower response time to task set-shifting and, the delayed response time correlated significantly with reduced GM density of the frontal lobes in migraineurs. Frontal and parietal lobe abnormalities in migraineurs could be an underlying cause of significantly slower response time during cognitive set-shifting.

Entities:  

Mesh:

Year:  2008        PMID: 18556120     DOI: 10.1016/j.neulet.2008.05.033

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  47 in total

Review 1.  Pain imaging in health and disease--how far have we come?

Authors:  Petra Schweinhardt; M Catherine Bushnell
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

2.  Individual differences in regional prefrontal gray matter morphometry and fractional anisotropy are associated with different constructs of executive function.

Authors:  H R Smolker; B E Depue; A E Reineberg; J M Orr; M T Banich
Journal:  Brain Struct Funct       Date:  2014-02-22       Impact factor: 3.270

Review 3.  Systematic review of neuroimaging correlates of executive functioning: converging evidence from different clinical populations.

Authors:  Milap A Nowrangi; Constantine Lyketsos; Vani Rao; Cynthia A Munro
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014-04-01       Impact factor: 2.198

4.  Atlas-based diffusion tensor imaging correlates of executive function.

Authors:  Milap A Nowrangi; Ozioma Okonkwo; Constantine Lyketsos; Kenichi Oishi; Susumu Mori; Marilyn Albert; Michelle M Mielke
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

Review 5.  Neuropsychological assessment in migraine patients: a descriptive review on cognitive implications.

Authors:  Maria Foti; Viviana Lo Buono; Francesco Corallo; Rosanna Palmeri; Placido Bramanti; Silvia Marino
Journal:  Neurol Sci       Date:  2017-01-18       Impact factor: 3.307

6.  Her versus his migraine: multiple sex differences in brain function and structure.

Authors:  Nasim Maleki; Clas Linnman; Jennifer Brawn; Rami Burstein; Lino Becerra; David Borsook
Journal:  Brain       Date:  2012-08       Impact factor: 13.501

Review 7.  Advanced neuroimaging of migraine.

Authors:  Todd J Schwedt; David W Dodick
Journal:  Lancet Neurol       Date:  2009-06       Impact factor: 44.182

8.  Interictal quantitative EEG in migraine: a blinded controlled study.

Authors:  Marte Helene Bjørk; Lars J Stovner; Morten Engstrøm; Marit Stjern; Knut Hagen; Trond Sand
Journal:  J Headache Pain       Date:  2009-08-25       Impact factor: 7.277

Review 9.  Migraine: What Imaging Reveals.

Authors:  Catherine D Chong; Todd J Schwedt; David W Dodick
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

Review 10.  Migraine and cognitive decline: a topical review.

Authors:  Pamela M Rist; Tobias Kurth
Journal:  Headache       Date:  2013-02-13       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.